JP2024503000A5 - - Google Patents

Info

Publication number
JP2024503000A5
JP2024503000A5 JP2023541286A JP2023541286A JP2024503000A5 JP 2024503000 A5 JP2024503000 A5 JP 2024503000A5 JP 2023541286 A JP2023541286 A JP 2023541286A JP 2023541286 A JP2023541286 A JP 2023541286A JP 2024503000 A5 JP2024503000 A5 JP 2024503000A5
Authority
JP
Japan
Prior art keywords
nucleic acid
acid molecule
sequence
seq
isolated polynucleotide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023541286A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024503000A (ja
JP7908943B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/011841 external-priority patent/WO2022150712A1/en
Publication of JP2024503000A publication Critical patent/JP2024503000A/ja
Publication of JP2024503000A5 publication Critical patent/JP2024503000A5/ja
Priority to JP2026082625A priority Critical patent/JP2026121509A/ja
Application granted granted Critical
Publication of JP7908943B2 publication Critical patent/JP7908943B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023541286A 2021-01-08 2022-01-10 発現構築物およびその使用 Active JP7908943B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026082625A JP2026121509A (ja) 2021-01-08 2026-05-15 発現構築物およびその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163135501P 2021-01-08 2021-01-08
US63/135,501 2021-01-08
PCT/US2022/011841 WO2022150712A1 (en) 2021-01-08 2022-01-10 Expression constructs and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026082625A Division JP2026121509A (ja) 2021-01-08 2026-05-15 発現構築物およびその使用

Publications (3)

Publication Number Publication Date
JP2024503000A JP2024503000A (ja) 2024-01-24
JP2024503000A5 true JP2024503000A5 (cg-RX-API-DMAC7.html) 2025-01-20
JP7908943B2 JP7908943B2 (ja) 2026-08-20

Family

ID=

Similar Documents

Publication Publication Date Title
Li et al. mRNA vaccine in cancer therapy: Current advance and future outlook
Fu et al. mRNA vaccines in the context of cancer treatment: from concept to application
JP2023535225A5 (cg-RX-API-DMAC7.html)
ES2861001T3 (es) Polirribonucleótidos que codifican la familia del casete de unión a ATP y formulaciones de los mismos
JP2022524391A5 (cg-RX-API-DMAC7.html)
JP7139307B2 (ja) Rnaの投与のための配合物
WO2016206626A1 (zh) 一种siRNA、含有该siRNA的药物组合物和缀合物及它们的应用
EP3373965A1 (en) Rotavirus vaccines
JP7808695B2 (ja) タンパク質発現のためのmRNA及びそのための鋳型
JP2020072720A (ja) Vlp−レプリコンを用いたクラスii mhc抗原の送達による癌免疫療法
DeFranciscis et al. Clinical applications of oligonucleotides for cancer therapy
JP2023523414A5 (cg-RX-API-DMAC7.html)
JP2003525222A (ja) Il−12をコードする核酸分子の腫瘍内投与
Copur Messenger RNA Vaccines: Beckoning of a New Era in Cancer Immunotherapy.
Dixit et al. Functionalised ligand-based nanomaterial drug targeting approaches for colorectal cancer therapy
Habibizadeh et al. Nanoparticle-mediated gene delivery of TRAIL to resistant cancer cells: a review
Lu et al. Novel modifications and delivery modes of cyclic dinucleotides for STING activation in cancer treatment
Galant et al. mRNA vaccines in the treatment of cancer
JP2025516226A5 (cg-RX-API-DMAC7.html)
KR20230129479A (ko) 발현 구성체 및 이의 용도
JP2024542126A5 (cg-RX-API-DMAC7.html)
Hang et al. mRNA-based therapies and their clinical prospects
Lundstrom Alphaviruses in cancer immunotherapy
JP2025501772A (ja) コロナウイルスワクチン
WO2025051146A9 (zh) 冠状病毒的3cl蛋白酶用于预防或治疗肿瘤的用途